Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Gormley Glenn — Aktis Oncology, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Gormley Glenn

Gormley Glenn

Director at Aktis Oncology, Inc. · on record since Apr 16, 2026

Insider trading activity of Gormley Glenn

Transactions on record: 1; since Apr 16, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 16, 2026

Figures computed from official regulatory filings — methodology.

Companies where Gormley Glenn has traded

Aktis Oncology, Inc.1 tx · Apr 16, 2026

Track record of Gormley Glenn

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gormley Glenn

Co-insiders of Gormley Glenn

Aichele DavidAktis Oncology, Inc.
Boller KennethAktis Oncology, Inc.
Boomgarden MarkAktis Oncology, Inc.
Cheema KamranAktis Oncology, Inc.
Czibere AkosAktis Oncology, Inc.
Denbaars StevenAktis Oncology, Inc.
EcoR1 Capital, LLCAktis Oncology, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

EVNIN LUKEAktis Oncology, Inc.

Feldman Paul LAktis Oncology, Inc.

Foley ToddAktis Oncology, Inc.

Frizzley Jill KathleenAktis Oncology, Inc.

GADICKE ANSBERTAktis Oncology, Inc.

Geiss ArthurAktis Oncology, Inc.

Herrmann KenAktis Oncology, Inc.

Houlden RohanAktis Oncology, Inc.

Kahn MatthewAktis Oncology, Inc.

Kim Helen SusanAktis Oncology, Inc.

KURTZWEIL JOHN TAktis Oncology, Inc.

Kuvalanka Kyle D.Aktis Oncology, Inc.

LILLY ELI & COAktis Oncology, Inc.

McGuire James MichaelAktis Oncology, Inc.

McMahon JeffreyAktis Oncology, Inc.

MILLER STEVEN PAktis Oncology, Inc.

MPM ASSET MANAGEMENT INVESTORS BV2018 LLCAktis Oncology, Inc.

MPM ASSET MANAGEMENT LLCAktis Oncology, Inc.

MPM BIOVENTURES 2018 (B), L.P.Aktis Oncology, Inc.

MPM BioVentures 2018 GP LLCAktis Oncology, Inc.

MPM BioVentures 2018 LLCAktis Oncology, Inc.

MPM BIOVENTURES 2018, L.P.Aktis Oncology, Inc.

MPM Oncology Innovations Fund GP LLCAktis Oncology, Inc.

MPM ONCOLOGY INNOVATIONS FUND LPAktis Oncology, Inc.

NEAL JERRY DAktis Oncology, Inc.

NODELMAN OLEGAktis Oncology, Inc.

Oncology Impact Private Investment Fund 2, L.P.Aktis Oncology, Inc.

Payne CindyAktis Oncology, Inc.

Petock MichelleAktis Oncology, Inc.

RODEN MATTHEWAktis Oncology, Inc.

Ron-Bigger ShulamitAktis Oncology, Inc.

RUDY SUZANNE BAktis Oncology, Inc.

Segal Lloyd MitchellAktis Oncology, Inc.

Shealy JeffreyAktis Oncology, Inc.

Sherman Michael A.Aktis Oncology, Inc.

Thistle MaryAktis Oncology, Inc.

Tompkins Mark N.Aktis Oncology, Inc.

VIDA VENTURES II-A, LLCAktis Oncology, Inc.

Vida Ventures II, LLCAktis Oncology, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aktis Oncology, Inc.	Apr 16, 2026	AwardD	37,866	0.00 USD	$0	SEC